Literature DB >> 1609829

Hemifacial microsomia: developmental consequence of perturbation of the auriculofacial cartilage model?

R R Cousley1, D J Wilson.   

Abstract

The cause of hemifacial microsomia (HFM) is currently the subject of much investigation. Despite a large body of clinical and experimental data, little is certain other than the heterogeneity of this malformation complex. Here we suggest that some of the cases previously designated as being multifactorial in origin may be interpreted instead as resulting from a single-gene mutation, by applying a stochastic single-gene model. A variety of models of the pathogenesis of HFM have been described, including the proposal that local embryonic haemorrhage is a causal mechanism. More recently, it has been suggested that an interference in chondrogenesis is primarily responsible for the HFM phenotype. In this paper direct experimental evidence, based on surgical interference of mandibular development in the chick embryo, is applied in favour of the latter concept. In particular, asymmetrical perturbation of Meckel's cartilage has been shown to result in asymmetry of the mandible, and it is proposed that, irrespective of cause, the skeletal pathogenesis of HFM primarily involves the auriculofacial cartilage model.

Entities:  

Mesh:

Year:  1992        PMID: 1609829     DOI: 10.1002/ajmg.1320420410

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

Review 1.  Hemifacial microsomia: skeletal abnormalities evaluation using CBCT (case report).

Authors:  Sergey Lvovich Kabak; Nina Alexandrovna Savrasova; Valentina Vladimirovna Zatochnaya; Yuliya Michailovna Melnichenko
Journal:  J Radiol Case Rep       Date:  2019-11-30

Review 2.  New therapeutics in promoting and modulating mandibular growth in cases with mandibular hypoplasia.

Authors:  Tarek El-Bialy; Adel Alhadlaq
Journal:  Biomed Res Int       Date:  2013-05-29       Impact factor: 3.411

3.  Nonsurgical Treatment of Hemifacial Microsomia: A Case Report.

Authors:  Mahtab Nouri; Arash Farzan
Journal:  Iran Red Crescent Med J       Date:  2015-11-01       Impact factor: 0.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.